token,surprisal
 .,10.0187406539917
 Jenny,21.14357566833496
 Hope,13.940905570983887
 Medical,16.284757614135742
 Correspond,15.156859397888184
ent,1.6844592094421387
 .,4.945896148681641
 PU,16.505905151367188
BL,0.3712785840034485
ISH,0.8744655847549438
ED,0.11081793904304504
:,7.884443759918213
 .,11.382715225219727
 19,10.980557441711426
:,7.428170204162598
50,6.140771865844727
 EST,5.985904693603516
",",2.114933729171753
 5,6.586665630340576
 March,5.09820032119751
 2014,4.037463665008545
 .,2.9883248805999756
 |,11.28697395324707
 .,5.574728488922119
 U,10.489928245544434
PDATED,3.158515214920044
:,0.9006393551826477
 .,2.5623104572296143
 19,3.039295196533203
:,0.003213374176993966
50,1.627308964729309
 EST,0.09836751967668533
",",0.0214336309581995
 5,1.00202214717865
 March,0.01192350685596466
 2014,0.008734989911317825
 .,0.46384304761886597
 Hundreds,15.852072715759277
 of,0.33669543266296387
 women,5.936588287353516
 in,4.083440780639648
 England,6.775771141052246
 are,2.9235291481018066
 to,6.377671718597412
 be,2.952395439147949
 the,7.134853839874268
 first,0.7968548536300659
 in,2.6693782806396484
 the,0.9172803163528442
 world,1.3246034383773804
 to,0.09044297784566879
 benefit,9.27694320678711
 from,0.05888046324253082
 a,2.3762717247009277
 drug,8.59487533569336
 for,7.087512969970703
 advanced,11.433308601379395
 cervical,4.012428283691406
 cancer,0.08374319970607758
 -,5.260981559753418
 the,2.686032772064209
 most,7.074002265930176
 common,3.924701452255249
 cancer,3.2864763736724854
 affecting,7.452772617340088
 young,5.001598834991455
 women,0.6478560566902161
.,1.036771535873413
 Trials,13.547362327575684
 show,6.4675679206848145
 Av,16.311328887939453
ast,1.932734489440918
in,1.5188030004501343
",",2.663656711578369
 which,2.9542124271392822
 is,1.9527819156646729
 already,5.659371376037598
 used,3.177774429321289
 in,1.7774726152420044
 other,7.430160045623779
 cancers,4.553554534912109
",",0.7093695402145386
 gives,9.489316940307617
 women,1.834531307220459
 almost,9.243496894836426
 four,6.107536315917969
 months,4.116696834564209
�,22.822460174560547
�,11.760706901550293
 extra,10.646669387817383
 life,5.702449321746826
.,3.27201247215271
 The,3.0087831020355225
 drug,3.0563876628875732
 will,4.456005096435547
 be,1.6796098947525024
 available,1.7364171743392944
 to,2.7258808612823486
 patients,4.696643829345703
 via,12.156317710876465
 the,2.223748207092285
 Cancer,10.034595489501953
 Drugs,3.8031558990478516
 Fund,5.253274917602539
 despite,12.507075309753418
 not,7.672333240509033
 yet,3.1911327838897705
 having,5.8643364906311035
 a,4.77207088470459
 licence,4.004086971282959
 for,4.332600116729736
 cervical,11.017853736877441
 cancer,0.07976101338863373
.,1.6875405311584473
 Success,14.518726348876953
ful,2.1536684036254883
:,13.25484561920166
 Av,2.554845094680786
ast,0.0034592754673212767
in,0.00161814596503973
",",4.543741226196289
 which,1.4439016580581665
 is,1.0618315935134888
 already,0.7547287344932556
 used,0.22127333283424377
 in,0.07280943542718887
 other,0.08678040653467178
 cancers,0.08099249750375748
",",0.16193021833896637
 could,13.08413028717041
 give,3.307509422302246
 women,1.0898444652557373
 almost,1.3371407985687256
 four,0.08146200329065323
 months,0.007429917808622122
 of,3.6807355880737305
 extra,0.11633124947547913
 life,0.06801013648509979
 .,5.7703537940979
 Experts,9.761280059814453
 at,6.1152238845825195
 NHS,6.764755725860596
 England,1.0586557388305664
 decided,12.524300575256348
 to,1.064812421798706
 add,8.95022201538086
 it,5.797145843505859
 to,0.1742914766073227
 the,1.4169667959213257
 list,2.3560097217559814
 of,0.39343947172164917
 approved,6.433955669403076
 medicines,3.4037728309631348
 after,3.7593281269073486
 requests,11.928977012634277
 for,3.22115421295166
 access,8.033126831054688
 from,2.7176132202148438
 on,11.519289016723633
c,1.566895604133606
ologists,0.37967556715011597
 and,2.7778685092926025
 following,14.379152297973633
 review,8.8573637008667
 of,1.3888789415359497
 the,2.003387451171875
 positive,12.584148406982422
 trial,7.750131130218506
 results,3.151463031768799
.,0.6708049178123474
 Professor,10.31222152709961
 Peter,5.987444877624512
 Clark,9.360968589782715
",",0.7389256358146667
 Chair,7.357717990875244
 of,0.2997007369995117
 the,0.8246945738792419
 Chem,13.802948951721191
otherapy,0.9070603251457214
 CR,17.462661743164062
G,8.646798133850098
",",3.9356653690338135
 said,0.5828943252563477
 �,17.03314971923828
�,8.978157997131348
This,7.356884956359863
 new,4.672737121582031
 addition,8.02310848236084
 to,1.6433048248291016
 the,0.2817893922328949
 list,0.5388777852058411
 demonstrates,8.287860870361328
 NHS,9.586320877075195
 England,0.17909272015094757
�,17.723026275634766
�,1.8333021402359009
s,2.1623682975769043
 commitment,0.4869999289512634
 to,0.06449472904205322
 achieving,8.94411849975586
 maximum,9.480329513549805
 benefit,2.3069231510162354
 to,2.5274078845977783
 patients,1.67950439453125
 from,5.716874122619629
 the,3.0495948791503906
 £,11.201345443725586
200,6.004533290863037
 million,2.0287961959838867
 Cancer,3.7933034896850586
 Drugs,0.22503693401813507
 Fund,0.19453851878643036
.,1.0304439067840576
 �,5.352168083190918
�,0.25796571373939514
The,2.5692105293273926
 process,11.74485969543457
 of,1.8467251062393188
 updating,9.074612617492676
 the,0.9765180349349976
 list,1.709544062614441
 is,3.708559513092041
 led,9.707560539245605
 by,0.020922793075442314
 cancer,10.294291496276855
 specialists,3.911353826522827
",",2.6869893074035645
 and,3.152806043624878
 should,7.8441619873046875
 ensure,5.580763339996338
 that,1.5726525783538818
 patients,2.930903196334839
 benefit,5.667452335357666
 quickly,9.773021697998047
 when,5.456160068511963
 new,3.802504062652588
 drugs,2.5461766719818115
 become,4.786377906799316
 available,0.029212918132543564
 that,8.389572143554688
 are,2.506321430206299
 backed,9.372314453125
 by,0.29392340779304504
 good,6.6237406730651855
 evidence,1.5995646715164185
 from,3.9366464614868164
 trial,7.418859004974365
 data,2.9106454849243164
.,0.7909584045410156
�,6.732626914978027
�,4.220693588256836
 It,6.0425944328308105
 is,1.235558271408081
 thought,7.273140907287598
 500,14.466675758361816
 women,2.889240026473999
 every,10.186359405517578
 year,1.0206246376037598
 could,5.716573715209961
 benefit,0.3023509979248047
 from,0.4310919940471649
 the,2.5043787956237793
 drug,2.2875890731811523
",",2.646005392074585
 which,1.7352774143218994
 is,1.629403829574585
 routinely,10.723637580871582
 available,6.141083717346191
 on,4.529949188232422
 the,1.5819711685180664
 NHS,0.11620225012302399
 before,9.435580253601074
 any,5.921492576599121
 other,3.6456825733184814
 country,13.131817817687988
 in,4.955663681030273
 the,0.41462811827659607
 world,0.20601792633533478
.,0.9298307299613953
 Suff,13.501675605773926
erer,7.332592010498047
:,2.289931535720825
 TV,15.283559799194336
 star,7.274426460266113
 Jade,10.719144821166992
 Good,10.487010955810547
y,6.472807884216309
 died,9.08641529083252
 in,2.6815454959869385
 March,4.206428527832031
 2009,7.637443542480469
 aged,5.357640266418457
 27,7.349254608154297
 after,1.2541314363479614
 a,2.77673077583313
 public,12.908013343811035
 battle,5.37579345703125
 with,0.7493680715560913
 cervical,3.3879823684692383
 cancer,0.037715304642915726
 .,5.658836841583252
 Nearly,10.868131637573242
 3,5.702678680419922
",",0.12684421241283417
000,0.34291449189186096
 women,1.102662444114685
 are,4.9743332862854
 diagnosed,6.031214714050293
 with,0.5219274759292603
 cervical,0.9021009802818298
 cancer,0.05053303390741348
 in,4.534299373626709
 the,1.4063761234283447
 UK,0.1282329112291336
 each,0.9146181344985962
 year,0.01858070306479931
",",2.4306728839874268
 and,2.3217086791992188
 it,6.184447288513184
 kills,4.203590393066406
 around,3.6325275897979736
 1,3.495800495147705
",",0.2993892729282379
000,1.1927449703216553
 women,2.811601400375366
.,5.917721271514893
 C,7.760388374328613
erv,0.08267645537853241
ical,0.028633708134293556
 cancer,0.11374282836914062
",",4.877528667449951
 which,1.4223859310150146
 is,2.132091522216797
 cancer,9.528216361999512
 of,1.279821753501892
 the,0.005537534132599831
 neck,8.86233901977539
 of,9.101031303405762
 the,0.09880523383617401
 womb,5.595427989959717
",",0.3799222707748413
 is,1.2921150922775269
 the,1.5802009105682373
 most,1.6264491081237793
 common,0.13185633718967438
 cancer,2.4817543029785156
 in,1.648842215538025
 women,1.0022679567337036
 aged,3.3679299354553223
 35,5.623167514801025
 and,2.37974214553833
 under,3.8433754444122314
.,0.5719107985496521
 It,3.1189050674438477
 is,1.439680814743042
 treated,6.857203960418701
 with,1.6562551259994507
 surgery,7.444736957550049
",",2.0760295391082764
 radi,7.541463851928711
otherapy,0.00988633930683136
 and,1.0178017616271973
 chemotherapy,0.4785853922367096
 and,3.2784111499786377
 if,9.741978645324707
 diagnosed,6.29026460647583
 and,9.10885238647461
 treated,0.1331695318222046
 early,6.566780090332031
 the,5.389165878295898
 outlook,12.002771377563477
 is,1.9103387594223022
 good,3.2576980590820312
.,0.7499838471412659
 However,5.489889621734619
",",0.17775148153305054
 for,6.58657169342041
 patients,4.860940933227539
 who,2.6032164096832275
 are,1.8724371194839478
 diagnosed,5.8342413902282715
 when,8.705440521240234
 their,3.534195899963379
 cancer,2.492279291152954
 is,1.5432249307632446
 at,6.842654228210449
 a,3.845566511154175
 more,5.320551872253418
 advanced,0.3627081513404846
 stage,0.01054668240249157
 it,3.570068597793579
 becomes,7.566667079925537
 more,1.8178234100341797
 difficult,2.16627836227417
 to,1.166190505027771
 treat,1.4851218461990356
 and,2.6999850273132324
 a,6.602038860321045
 cure,8.091947555541992
 is,0.9140325784683228
 unlikely,5.626281261444092
.,0.6119452714920044
 Reality,18.04355812072754
 TV,3.2763967514038086
 star,0.4539538621902466
 Jade,4.227605819702148
 Good,0.08058224618434906
y,0.0076034036464989185
 died,1.3405225276947021
 in,0.9400563836097717
 March,0.1888289749622345
 2009,0.04031946882605553
 aged,0.14370499551296234
 27,0.014258713461458683
 after,0.05268482118844986
 a,0.02537141554057598
 very,17.970142364501953
 public,0.3445036709308624
 battle,0.11870574206113815
 with,0.018286488950252533
 the,10.505597114562988
 disease,3.0721640586853027
.,0.6286121606826782
 The,6.275239944458008
 time,10.847521781921387
 between,5.417642116546631
 her,3.2941367626190186
 diagnosis,5.241020679473877
 and,0.12683115899562836
 death,3.676751136779785
 was,1.364553689956665
 just,6.117079257965088
 months,7.689976692199707
",",5.284073829650879
 suggesting,10.09801197052002
 her,4.132884979248047
 cancer,2.417896270751953
 was,1.2312997579574585
 already,4.560458183288574
 at,4.619387149810791
 an,2.8825812339782715
 advanced,0.17402058839797974
 stage,0.028722740709781647
 on,10.814521789550781
 diagnosis,11.951457977294922
 and,2.559687614440918
 within,10.8049898147583
 five,5.177938938140869
 months,2.834242343902588
 it,4.404982566833496
 had,3.719844102859497
 spread,1.0601625442504883
.,3.4751431941986084
 Av,10.061067581176758
ast,0.003541079582646489
in,0.0013942489167675376
",",2.4087636470794678
 which,0.8408292531967163
 is,0.781562864780426
 also,4.55178165435791
 known,3.188506841659546
 as,0.03655882552266121
 be,12.724663734436035
v,1.8433688879013062
ac,0.4134542942047119
iz,4.312695503234863
um,0.21684278547763824
ab,0.0001350126985926181
",",0.7055448293685913
 is,1.5109230279922485
 widely,7.12709379196167
 used,0.38450080156326294
 in,1.279191255569458
 patients,7.257583141326904
 with,1.5156230926513672
 colon,10.587767601013184
 cancer,0.3873238265514374
 and,2.093175172805786
 licensed,21.105731964111328
 for,2.3061938285827637
 four,10.667019844055176
 other,5.142488956451416
 types,3.1725285053253174
 of,0.24579346179962158
 cancer,1.1636165380477905
.,1.0550106763839722
 Trial,11.551504135131836
 findings,6.193788051605225
 show,2.916273593902588
 Av,2.4226319789886475
ast,0.005005284678190947
in,0.002679396653547883
 can,3.488176107406616
 extend,8.138799667358398
 the,3.572138786315918
 lives,3.4266955852508545
 of,0.023304084315896034
 women,3.985529899597168
 with,1.254044771194458
 advanced,1.946460247039795
 cervical,0.5893266201019287
 cancer,0.059262726455926895
 by,0.9333729147911072
 30,5.9131388664245605
 per,4.1213178634643555
 cent,0.00030194714781828225
 compared,6.207618713378906
 with,0.9052802324295044
 chemotherapy,6.112907886505127
.,2.5473806858062744
 Using,11.015028953552246
 the,2.0199224948883057
 drug,2.436223268508911
 led,11.216590881347656
 to,0.4669843912124634
 overall,13.747977256774902
 survival,1.7569659948349
 of,2.3256239891052246
 17,8.559600830078125
 months,5.620339870452881
 compared,4.318574905395508
 to,2.6740074157714844
 13,7.304633617401123
.,5.851975917816162
3,4.162717342376709
 months,0.6379404664039612
 and,7.415442943572998
 almost,8.771888732910156
 half,3.812077522277832
 of,1.416221022605896
 patients,2.983419895172119
 responded,8.766518592834473
 to,1.6720706224441528
 treatment,3.5404868125915527
.,1.684268832206726
 Robert,13.460517883300781
 Music,16.74650764465332
",",0.5756373405456543
 Chief,4.237204074859619
 Executive,0.40968844294548035
 of,0.28974437713623047
 Jo,16.61871337890625
�,16.18792724609375
�,2.119997024536133
s,3.0611445903778076
 C,5.871230602264404
erv,0.1065594032406807
ical,0.10769408196210861
 Cancer,0.2759927213191986
 Trust,2.816805601119995
",",0.7819469571113586
 said,0.21350790560245514
 �,4.955105304718018
�,0.31831592321395874
The,2.826964855194092
 addition,8.691727638244629
 of,0.6273539662361145
 be,8.947245597839355
v,0.0030808306764811277
ac,0.006139237899333239
iz,0.003944046795368195
um,0.002066130517050624
ab,0.0031685596331954002
 to,1.0288257598876953
 the,0.21453127264976501
 Cancer,4.147703170776367
 Drugs,0.043462276458740234
 Fund,0.12445882707834244
 is,2.717595338821411
 very,6.99736213684082
 positive,4.480626106262207
 as,6.754682540893555
 for,9.029824256896973
 women,4.325441837310791
 who,2.3883280754089355
 receive,7.15806770324707
 a,5.252498149871826
 late,10.049722671508789
 stage,5.7335205078125
 diagnosis,3.2724287509918213
 of,2.716245412826538
 cervical,2.2227187156677246
 cancer,0.023668553680181503
",",1.7625738382339478
 the,2.9467203617095947
 prog,8.322296142578125
nosis,0.005717699881643057
 can,6.444359302520752
 often,9.956547737121582
 be,0.4260697364807129
 poor,6.4805097579956055
.,0.8173343539237976
 Disease,15.159751892089844
:,9.027960777282715
 Experts,11.138609886169434
 at,1.12693190574646
 NHS,1.8431549072265625
 England,0.032220445573329926
 decided,1.3441860675811768
 to,0.15331977605819702
 add,0.0659605860710144
 Av,0.941716730594635
ast,0.0053220042027533054
in,0.004025102127343416
 to,0.3838511109352112
 the,0.01792825385928154
 list,0.14320558309555054
 of,0.009873352013528347
 approved,0.10384344309568405
 medicines,0.0907260924577713
 after,0.13390587270259857
 requests,1.1464347839355469
 for,0.7805509567260742
 access,0.0029184857849031687
 from,0.0028891898691654205
 on,0.037545572966337204
c,0.0010748619679361582
ologists,0.018012188374996185
 and,0.0756601020693779
 following,0.01447940431535244
 review,0.012632581405341625
 of,0.0023171764332801104
 the,0.06745965033769608
 positive,0.19559775292873383
 trial,0.018293369561433792
 results,0.04433111473917961
.,0.3183997571468353
 Above,12.484050750732422
",",3.22770094871521
 cells,14.8794584274292
 showing,9.463172912597656
 cervical,8.859365463256836
 cancer,0.3939523696899414
 .,8.570326805114746
 �,10.82735538482666
�,0.15027783811092377
When,8.186724662780762
 this,6.197700023651123
 is,4.318162441253662
 the,5.5807271003723145
 case,0.21820488572120667
",",0.7242656350135803
 any,8.29217529296875
 extra,7.473662376403809
 time,4.903138637542725
 that,4.260095119476318
 can,5.684317588806152
 be,0.11405623704195023
 provided,6.402838230133057
 through,7.100499629974365
 new,7.801096439361572
 drugs,2.3048927783966064
 becomes,8.355924606323242
 extremely,5.6854248046875
 valuable,0.802145779132843
.,1.0373306274414062
 We,7.073319435119629
 hope,3.7113912105560303
 this,2.725611686706543
 will,2.2390666007995605
 result,7.851821422576904
 in,0.025235595181584358
 extended,11.389951705932617
 survival,4.761727333068848
 without,8.68764877319336
 impacting,12.068575859069824
 on,0.8486902713775635
 quality,6.30738639831543
 of,0.1484440416097641
 life,0.09352928400039673
 for,3.227457284927368
 those,4.664303779602051
 facing,8.554511070251465
 non,10.813106536865234
-,0.05174301937222481
cur,11.4486722946167
ative,1.5758472681045532
 treatment,6.252691268920898
.,0.934598982334137
�,5.283572196960449
�,1.6104238033294678
 The,3.660156488418579
 Cancer,4.3417277336120605
 Drugs,0.04302863031625748
 Fund,0.028470303863286972
 provides,6.938909530639648
 an,5.5563883781433105
 additional,2.850572347640991
 £,0.5212056040763855
200,2.6556620597839355
m,2.8184499740600586
 each,4.437527656555176
 year,0.041311271488666534
 to,0.7309409976005554
 enable,9.107353210449219
 patients,3.275613784790039
 with,2.4918789863586426
 cancer,3.0001509189605713
 in,5.89447021484375
 England,2.411565065383911
 to,0.44072479009628296
 access,4.269590377807617
 drugs,5.692057132720947
 that,2.084036350250244
 are,1.6151072978973389
 not,5.01438570022583
 routinely,7.204879283905029
 funded,9.843628883361816
 by,1.8382316827774048
 their,6.389369487762451
 local,2.6446762084960938
 NHS,0.7384843826293945
.,1.4458085298538208
 The,2.9492428302764893
 national,9.692715644836426
 Cancer,1.1616144180297852
 Drugs,0.13845887780189514
 Fund,0.10756974667310715
 list,16.60503387451172
 is,2.047708511352539
 a,5.27683687210083
 single,9.922099113464355
 national,5.1916913986206055
 list,4.896949768066406
 of,1.1422861814498901
 approved,1.7350846529006958
 fast,20.55925750732422
-,0.9401844143867493
track,4.880552291870117
 drugs,1.17448890209198
 giving,11.914176940917969
 uniform,17.371732711791992
 access,2.744448661804199
 to,0.25025811791419983
 treatment,6.251851558685303
 across,4.95250129699707
 the,1.1707797050476074
 country,2.068612575531006
.,0.7240528464317322
 From,9.118317604064941
 1,5.704040050506592
 April,3.1106116771698
",",2.669215202331543
 NHS,4.629806995391846
 England,0.016538817435503006
 took,14.541647911071777
 on,6.0442376136779785
 responsibility,7.264222621917725
 for,0.21284250915050507
 the,2.4314942359924316
 operational,11.58658218383789
 management,4.106461524963379
 of,0.23149621486663818
 the,0.7278804183006287
 Cancer,1.5114679336547852
 Drugs,0.022318031638860703
 Fund,0.04692194238305092
.,1.722019910812378
 A,5.891481876373291
 spokesman,6.5129499435424805
 for,2.626953601837158
 Roche,17.77126693725586
",",3.974170684814453
 which,1.4894797801971436
 makes,3.5037920475006104
 Av,0.6886574625968933
ast,0.005439216736704111
in,0.0022077958565205336
",",0.3347543179988861
 said,0.33771073818206787
 NHS,8.74722671508789
 England,0.019210094586014748
 had,2.5274462699890137
 made,4.604325771331787
 the,3.0165460109710693
 life,15.282197952270508
 extending,15.353836059570312
 treatment,4.836862564086914
 routinely,15.811774253845215
 available,0.2878023684024811
 on,5.03384256362915
 the,1.0746022462844849
 NHS,0.33637869358062744
 before,6.402712821960449
 any,3.826359272003174
 other,0.28159505128860474
 country,0.2372288852930069
 in,0.8054016828536987
 the,0.03590233996510506
 world,0.01026484090834856
.,0.48017770051956177
 �,5.184300899505615
�,0.1424509882926941
R,5.523558616638184
oche,0.0013286616886034608
 remains,9.910985946655273
 committed,0.297966331243515
 to,0.02529536560177803
 are,17.13255500793457
 working,11.345965385437012
 with,1.1201505661010742
 regulatory,11.951770782470703
 authorities,2.788339138031006
 to,1.4449996948242188
 seek,11.098299980163574
 a,3.363830089569092
 licence,1.476677417755127
 for,1.193763017654419
 Av,2.605583667755127
ast,0.005060856696218252
in,0.0026074619963765144
 in,4.358179092407227
 advanced,10.683822631835938
 cervical,0.46951138973236084
 cancer,0.09756167232990265
�,12.886750221252441
�,0.12652331590652466
 she,14.473458290100098
 added,1.5654791593551636
.,0.3397309482097626
